{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:16:38Z","timestamp":1772266598657,"version":"3.50.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186778","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T17:37:22Z","timestamp":1509385042000},"page":"e0186778","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-2166","authenticated-orcid":true,"given":"Jonathon R.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Sadatsafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Kevin","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"ref1","article-title":"Canadian Tuberculosis Standards","year":"2013"},{"issue":"8","key":"ref2","first-page":"387","article-title":"TB in foreign-born patients","volume":"54","author":"D Roth","year":"2012","journal-title":"BC Med J"},{"key":"ref3","first-page":"615","article-title":"The epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989\u20131998: identification of high risk groups","volume":"6","author":"R Long","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"E473","DOI":"10.1503\/cmaj.150011","article-title":"Domestic impact of tuberculosis screening among new immigrants to Ontario, Canada","volume":"187","author":"K Khan","year":"2015","journal-title":"Can Med Assoc J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1164\/ajrccm.158.6.9804029","article-title":"Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons","volume":"158","author":"DP Chin","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/JCM.01946-08","article-title":"Mycobacterium tuberculosis in Ontario, Canada: Insights from IS6110 restriction fragment length polymorphism and mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping","volume":"47","author":"DC Alexander","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup","volume":"179","author":"KM Shea","year":"2014","journal-title":"Am J Epidemiol"},{"key":"ref8","first-page":"555","article-title":"International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"H Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMsa021099","article-title":"Global Drug-Resistance Patterns and the Management of Latent Tuberculosis Infection in Immigrants to the United States","volume":"347","author":"K Khan","year":"2002","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1164\/ajrccm.162.6.2001111","article-title":"Comparison of Cost-Effectiveness of Tuberculosis Screening of Close Contacts and Foreign-Born Populations","volume":"162","author":"K Dasgupta","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"BP Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","unstructured":"Canada Facts and Figures: Immigrant Overview Permanent Residents 2014. Government of Canada: Immigration, Refugees and Citizenship Canada. 2015. http:\/\/publications.gc.ca\/site\/eng\/9.512569\/publication.html<\/ext-link> [accessed May 11, 2017]"},{"key":"ref14","unstructured":"BCG World Atlas, 2nd Edition. 2017. http:\/\/www.bcgatlas.org<\/ext-link> [accessed May 11, 2017]"},{"key":"ref15","unstructured":"WHO-UNICEF Estimates of BCG Coverage. World Health Organization. 2017. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragebcg.html<\/ext-link> [accessed May 11, 2017]"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201308-1480OC","article-title":"Persistent latent tuberculosis reactivation risk in United States immigrants","volume":"189","author":"ND Walter","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/S0140-6736(16)31008-X","article-title":"Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland","volume":"388","author":"RW Aldridge","year":"2016","journal-title":"Lancet"},{"key":"ref18","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"SH Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence","volume":"99","author":"GW Comstock","year":"1974","journal-title":"Am J Epidemiol"},{"key":"ref20","first-page":"161","article-title":"A controlled trial of isoniazid prophylaxis in mental institutions","volume":"88","author":"SH Ferebee","year":"1963","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/00039896.1971.10665820","article-title":"Height, weight, tuberculosis infection, and tuberculosis disease","volume":"22","author":"LB Edwards","year":"1971","journal-title":"Arch Environ Health"},{"key":"ref22","article-title":"Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis","volume":"0","author":"IHY Chan","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref23","unstructured":"Guidelines for the Economic Evaluation of Health Technologies: Canada (4th Edition, 2017). Canadian Agency for Drugs and Technologies in Health. 2017. https:\/\/www.cadth.ca\/guidelines-economic-evaluation-health-technologies-canada-4th-edition<\/ext-link> [accessed August 16, 2017]."},{"key":"ref24","first-page":"473","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations","volume":"146","author":"A Laupacis","year":"1992","journal-title":"Can Med Assoc J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"E Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"PJ Neumann","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"GD Sanders","year":"2016","journal-title":"JAMA"},{"key":"ref28","unstructured":"Life Tables, Canada, Provinces and Territories 2010\u20132012. Government of Canada: Statistics Canada. 2016. http:\/\/www5.statcan.gc.ca\/olc-cel\/olc.action?objId=84-537-X&objType=2&lang=en&limit=0<\/ext-link> [accessed May 11, 2017]."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40291-014-0125-0","article-title":"A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants","volume":"19","author":"JR Campbell","year":"2015","journal-title":"Mol Diagn Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"D Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"M Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"4","key":"ref32","first-page":"517","article-title":"Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build","volume":"76","author":"CE Palmer","year":"1957","journal-title":"Am Rev Tuberc"},{"issue":"2","key":"ref33","first-page":"171","article-title":"Long-term results of BCG vaccination in the southern United States","volume":"93","author":"GW Comstock","year":"1966","journal-title":"Am Rev Respir Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"CR Horsburgh Jr","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1164\/rccm.200909-1355OC","article-title":"Revisiting Rates of Reactivation Tuberculosis: A Population-based Approach","volume":"182","author":"CR Horsburgh Jr.","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40291-015-0135-6","article-title":"Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis","volume":"19","author":"JR Campbell","year":"2015","journal-title":"Mol Diagn Ther"},{"key":"ref37","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts","volume":"12","author":"F Marra","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1524-4733.2008.00334.x","article-title":"Cost-effectiveness of LTBI treatment for TB contacts in British Columbia","volume":"11","author":"MC Tan","year":"2008","journal-title":"Value Health"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF03405248","article-title":"Costs for tuberculosis care in Canada","volume":"99","author":"D Menzies","year":"2008","journal-title":"Can J Public Health"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","article-title":"Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection","volume":"179","author":"DP Holland","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpainsymman.2009.04.007","article-title":"Cost trajectories at the end of life: the Canadian experience","volume":"38","author":"K Fassbender","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11136-014-0858-6","article-title":"The impact of tuberculosis on health utility: a longitudinal cohort study","volume":"24","author":"M Bauer","year":"2015","journal-title":"Qual Life Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1524-4733.2008.00355.x","article-title":"Health state utilities in latent and active tuberculosis","volume":"11","author":"N Guo","year":"2008","journal-title":"Value Health"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1378\/chest.07-1494","article-title":"Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection","volume":"133","author":"CA Marra","year":"2008","journal-title":"Chest"},{"key":"ref45","first-page":"A6507","article-title":"Effectiveness Of Pre-Immigration Screening And Post-Arrival Surveillance To Detect Active And Latent Tuberculosis In The Foreign Born: A Systematic Review And Meta-Analysis","volume":"185","author":"N Bettache","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/thx.2009.125054","article-title":"Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB","volume":"65","author":"A Aspler","year":"2010","journal-title":"Thorax"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10096-012-1788-2","article-title":"Cost-effectiveness of rifampin for 4 months and isoniazid for 9 months in the treatment of tuberculosis infection","volume":"32","author":"JM Pina","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study","volume":"166","author":"KR Page","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1378\/chest.130.6.1712","article-title":"Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin","volume":"130","author":"A Lardizabal","year":"2006","journal-title":"Chest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months","volume":"170","author":"D Menzies","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref51","first-page":"560","article-title":"Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis","volume":"159","author":"SR Salpeter","year":"1993","journal-title":"West J Med"},{"key":"ref52","first-page":"257","article-title":"Recent developments in treatment of latent tuberculosis infection","volume":"133","author":"D Menzies","year":"2011","journal-title":"Indian J Med Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.200405-584PP","article-title":"Considering the Role of Four Months of Rifampin in the Treatment of Latent Tuberculosis Infection","volume":"170","author":"LB Reichman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.200408-1081OC","article-title":"Recurrent tuberculosis in the United States and Canada: relapse or reinfection?","volume":"170","author":"RM Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"1601546","DOI":"10.1183\/13993003.01546-2016","article-title":"Impact of interferon-\u03b3 release assay on the latent tuberculosis cascade of care: a population-based study","volume":"49","author":"DZ Roth","year":"2017","journal-title":"Eur Respir J"},{"key":"ref56","first-page":"16","article-title":"Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis","volume":"11","author":"O Oxlade","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e015108","DOI":"10.1136\/bmjopen-2016-015108","article-title":"Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study","volume":"7","author":"AR Patel","year":"2017","journal-title":"BMJ Open"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40258-015-0183-4","article-title":"A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection","volume":"13","author":"JR Campbell","year":"2015","journal-title":"Appl Health Econ Health Policy"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tube.2016.04.007","article-title":"A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups","volume":"99","author":"P Auguste","year":"2016","journal-title":"Tuberculosis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12913-015-1045-3","article-title":"A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries","volume":"15","author":"L Zammarchi","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","article-title":"Populating an economic model with health state utility values: moving toward better practice","volume":"13","author":"R Ara","year":"2010","journal-title":"Value Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T21:41:45Z","timestamp":1659735705000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186778"}},"subtitle":[],"editor":[{"given":"Pere-Joan","family":"Cardona","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":61,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186778","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]}}}